A neurosurgery team will next month transplant cells from aborted human fetuses into the brain of a person with Parkinson’s disease. But the trial comes just as other sources of replacement cells derived from human stem cells are rapidly approaching the clinic. The cellular therapies aim to replace the missing neurons with dopamine-producing (dopaminergic) cells from fetal brains or with those derived from human stem cells.

READ FULL ARTICLE Curated publisher From Nature